Washington Trust’s NuVasive, Inc. NUVA Stock Holding History

Washington Trust’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-700	Closed	-$38K	–	1039
2020 Q2	$38K	Buy	+700	New	+$40.5K	﹤0.01%	438

Other funds holding NUVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Washington Trust's NUVA Position: Q3 2020 in Review

Washington Trust sold out of NuVasive, Inc. (NUVA) in Q3 2020, closing a stake of 700 shares — an estimated $38K sold.

Washington Trust first reported a position in NUVA in Q2 2020 and held it in 1 quarter. The position peaked at $38K in Q2 2020. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2020.

Washington Trust reported no remaining NuVasive, Inc. position as of Q3 2020 after selling out during the quarter.
Washington Trust sold 700 NuVasive, Inc. shares in Q3 2020, an estimated $38K.
Washington Trust first reported a position in NuVasive, Inc. in Q2 2020 and held it in 1 quarter.
Washington Trust's NuVasive, Inc. position peaked at $38K in Q2 2020.
263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2020.

Based on Washington Trust's 13F filing for Q3 2020, filed 5 Nov 2020.